You are here: Industry Insights > Covaxin

News List

Bharat Biotech’s Covaxin may provide Covid-19 immunity for 12 months pharmaceutical-technology
February 18, 2021
All India Institute of Medical Sciences (AIIMS) said that Bharat Biotech’s Covid-19 vaccine, Covaxin, may provide immunity against the disease for nine to 12 months, as per the mathematical calculations.
Bharat Biotech to get Genome Valley Excellence Award at BioAsia 2021 expresspharma
February 18, 2021
Dr Krishna M Ella, Suchitra Ella and Dr Balram Bhargav are being honoured in BioAsia 2021.
Third Phase will begin in march and covers ages 50 and above: Harsh Vardhan expresspharma
February 08, 2021
On Friday, Health Minister Harsh Vardhan said in the Lok Sabha that the third phase of the vaccination drive is likely to begin in March.
Ocugen, Bharat Biotech announce agreement for commercialisation of Covaxin in US market expresspharma
February 03, 2021
Ocugen is also in active discussions with manufacturers in the US to produce a significant number of doses of COVAXIN to support its US immunisation programme.
Bharat Biotech gets Letter of Comfort for 45 lakh doses of Covaxin expresspharma
January 20, 2021
Bharat Biotech has received a fresh Letter of Comfort from Government of India for another 45 lakh doses of its COVID-19 vaccine, Covaxin, informed sources.
Bharat Biotech factsheet advises people with allergies, medical conditions to not take Covaxin expresspharma
January 19, 2021
The list also includes pregnant or breastfeeding women, and people who have received another COVID-19 vaccine.
Halt Bharat Biotech’s COVAXIN trial in Bhopal: Civil society organisations expresspharma
January 15, 2021
These organisations state that unethical conduct, protocol violations in a clinical trial where an apex government body is a co-sponsor is particularly alarming.
Bharat Biotech ships out COVAXIN to 11 cities expresspharma
January 14, 2021
It has received a government purchase order for 55 lakh doses, the company has also donated 16.5 lakh doses to the Government of India.
Bharat Biotech signs deal with Precisa Medicamentos for COVAXIN supply to Brazil expresspharma
January 13, 2021
Supplies will be prioritised for the public market through a direct procurement by the Government of Brazil, private market will get the vaccine after receipt of market authorisation from ANVISA.
Recipients cannot choose between two COVID vaccine options for now: GoI expresspharma
January 13, 2021
1.1 crore doses of Covishield from the Serum Institute of India and 55 lakh doses of Covaxin from Bharat Biotech - will be received by January 14, informed Rajesh Bhushan, Union Health Secretary.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page